000 | 01041 a2200265 4500 | ||
---|---|---|---|
005 | 20250516225319.0 | ||
264 | 0 | _c20150703 | |
008 | 201507s 0 0 eng d | ||
022 | _a1569-8041 | ||
024 | 7 |
_a10.1093/annonc/mdu289 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aBesse, B | |
245 | 0 | 0 |
_aPharmacogenomics in NSCLC: mostly unsexy but desperately needed. _h[electronic resource] |
260 |
_bAnnals of oncology : official journal of the European Society for Medical Oncology _cNov 2014 |
||
300 |
_a2099-2100 p. _bdigital |
||
500 | _aPublication Type: Editorial | ||
650 | 0 | 4 |
_aBiomarkers, Tumor _xgenetics |
650 | 0 | 4 |
_aCarcinoma, Non-Small-Cell Lung _xdrug therapy |
650 | 0 | 4 | _aClinical Trials as Topic |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aPharmacogenetics _xtrends |
700 | 1 | _aReck, M | |
773 | 0 |
_tAnnals of oncology : official journal of the European Society for Medical Oncology _gvol. 25 _gno. 11 _gp. 2099-2100 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1093/annonc/mdu289 _zAvailable from publisher's website |
999 |
_c24073498 _d24073498 |